Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples

PLoS ONE

Volumn 5, Issue 3, 2010, Pages

  Dheda, Keertan ^a,b,c   Davids, Virginia ^a   Lenders, Laura ^a   Roberts, Teri ^b   Meldau, Richard ^a   Ling, Daphne ^d   Brunet, Laurence ^d   Smit, Richard van Zyl ^a   Peter, Jonathan ^a   Green, Clare ^c   Badri, Motasim ^b   Sechi, Leonardo ^e   Sharma, Surendra ^f   Hoelscher, Michael ^g   Dawson, Rodney ^a   Whitelaw, Andrew ^b   Blackburn, Jonathan ^b   Pai, Madhukar ^d   Zumla, Alimuddin ^c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d MCGILL UNIVERSITY   (Canada)

^e UNIVERSITY OF SASSARI   (Italy)

^f ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^g LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALGORITHM; ARTICLE; CD4+ T LYMPHOCYTE; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SPUTUM; TREATMENT OUTCOME; TUBERCULOSIS; URINALYSIS; URINE; VIROLOGY;

ADULT; ALGORITHMS; CD4-POSITIVE T-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPUTUM; TREATMENT OUTCOME; TUBERCULOSIS; URINALYSIS;

EID: 77951080585     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009848     Document Type: Article

References (28)

1. WHO (2008) Global tuberculosis control: Surveillance, planning, financing. Geneva: World Health Organization.
2. Corbett E, Watt C, Walker N, et al. (2003) The growing burden of tuberculosis. Global trends and interactions with the HIV epidemic. Arch Intern Med 163: 1009-1021.
3. Stop TB Partnership (2006) Geneva: World Health Organisation.
4. New Diagnostic Working Group of the Stop TB Partnership (2009) Pathways to better diagnostics for tuberculosis-A blueprint for the development of TB diagnostics. World Health Organisation.
5. GetahunH, HarringtonM, O'Brien R, Nunn P (2007) Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resourceconstrained settings: informing urgent policy changes. Lancet 369: 2042-2049.
6. Burman W, Jones B (2003) Clinical and radiographic features of HIV-related tuberculosis. Semin Respir Infect 18: 263-271.
7. Pai M, Kalantri S, Dheda K (2006) New tools and emerging technologies for the diagnosis of tuberculosis: part II. Active tuberculosis and drug resistance. Expert Rev Mol Diagn 6: 423-432.
8. Dheda K, Smit RZ, Badri M, Pai M (2009) T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in highburden vs. low-burden settings. Curr Opin Pulm Med 15: 188-200.
9. Pai M, Minion J, Sohn H, Zwerling A, Perkins MD (2009) Novel and improved technologies for tuberculosis diagnosis: progress and challenges. Clin Chest Med 30: 701-716, viii.
10. Boehme C, Molokova E, Minja F, Geis S, Loscher T, et al. (2005) Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis. Trans R Soc Trop Med Hyg 99: 893-900.
11. Hamasur B, Bruchfeld J, Haile M, Pawlowski A, Bjorvatn B, et al. (2001) Rapid diagnosis of tuberculosis by detection of mycobacterial lipoarabinomannan in urine. J Microbiol Methods 45: 41-52.
12. Tessema TA, Hamasur B, Bjun G, Svenson S, Bjorvatn B (2001) Diagnostic evaluation of urinary lipoarabinomannan at an Ethiopian tuberculosis centre. Scand J Infect Dis 33: 279-284.
13. Patel VB, Bhigjee AI, Paruk HF, Singh R, Meldau R, et al. (2009) Utility of a novel lipoarabinomannan assay for the diagnosis of tuberculous meningitis in a resource-poor high-HIV prevalence setting. Cerebrospinal Fluid Res 6: 13.
14. Dheda K, Van-Zyl Smit RN, Sechi LA, Badri M, Meldau R, et al. (2009) Clinical diagnostic utility of IP-10 and LAM antigen levels for the diagnosis of tuberculous pleural effusions in a high burden setting. PLoS One 4: e4689.
15. Lawn SD, Edwars DJ, Kranzer K, Vogt M, Bekker L-G, et al. (2009) Urine lipoarabinomannan assay for tuberculosis screening prior to ART: diagnostic yield and association with immune reconstitution disease.
16. Mutetwa R, Boehme C, Dimairo M, Mangwanya D, Munyati S, et al. (2009) Diagnostic accuracy of commercial urinary lipoarabinomannandetection in African TB suspects and patients. The International Journal of Tuberculosis and Lung Disease.
17. Reither K, Saathoff E, Jung J, Minja L, Kroidl I, et al. (2009) Low sensitivity of a urine LAM-ELISA in the diagnosis of pulmonary tuberculosis.
18. Shah M, Variava E, Holmes CB, Coppin A, Golub JE, et al. (2009) Diagnostic Accuracy of a Urine Lipoarabinomannan Test for Tuberculosis in Hospitalized Patients in a High HIV Prevalence Setting. J Acquir Immune Defic Syndr.
19. Daley P, Michael JS, Hmar P, Latha A, Chordia P, et al. (2009) Blinded evaluation of commercial urinary lipoarabinomannan for active tuberculosis: a pilot study. Int J Tuberc Lung Dis 13: 989-995.
20. Wilson D, Nachega J, Morroni C, Chaisson R, Maartens G (2006) Diagnosing smear-negative tuberculosis using case definitions and treatment response in HIV-infected adults. Int J Tuberc Lung Dis 10: 31-38.
21. Moons KG, Biesheuvel CJ, Grobbee DE (2004) Test research versus diagnostic research. Clin Chem 50: 473-476.
22. Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143: 29-36.
23. Harrell FE, Jr., Califf RM, Pryor DB, Lee KL, Rosati RA (1982) Evaluating the yield of medical tests. Jama 247: 2543-2546.
24. Alvarado-Esquivel C, Garcia-Corral N, Carrero-Dominguez D, Enciso-Moreno JA, Gurrola-Morales T, et al. (2009) Molecular analysis of Mycobacterium isolates from extrapulmonary specimens obtained from patients in Mexico. BMC Clin Pathol 9: 1.
25. Sittampalam GS, Smith WC, Miyakawa TW, Smith DR, McMorris C (1996) Application of experimental design techniques to optimize a competitive ELISA. J Immunol Methods 190: 151-161.
26. Quaggin SE (2009) Genetic susceptibility to HIV-associated nephropathy. J Clin Invest 119: 1085-1089.
27. Doublier S, Zennaro C, Spatola T, Lupia E, Bottelli A, et al. (2007) HIV-1 Tat reduces nephrin in human podocytes: a potential mechanism for enhanced glomerular permeability in HIV-associated nephropathy. Aids 21: 423-432.
28. Pereira Arias-Bouda LM, Nguyen LN, Ho LM, Kuijper S, Jansen HM, et al. (2000) Development of antigen detection assay for diagnosis of tuberculosis using sputum samples. J Clin Microbiol 38: 2278-2283.